Cytokinetics, Inc.

634 articles about Cytokinetics, Inc.

• Cytokinetics, Inc. Announces Selection Of CK-1827452 As Development Candidate For Chronic Heart Failure

  12/8/2005

• Cytokinetics, Inc. Sponsors Fourth Special Interest Subgroup On Function And Regulation Of Actin-Myosin Interactions

  12/5/2005

• Cytokinetics, Inc. Announces Interim Phase II Breast Cancer Data For Ispinesib To Be Presented At San Antonio Breast Cancer Symposium

  12/2/2005

• Cytokinetics, Inc. To Present At The Lazard Capital Markets Life Sciences Conference

  11/23/2005

• Cytokinetics, Inc. Announces Clinical And Non-Clinical Results For Ispinesib At The 2005 Annual AACR-NCI-EORTC Meeting

  11/18/2005

• Cytokinetics, Inc. To Present At The Credit Suisse First Boston Annual Health Care Conference

  11/14/2005

• Cytokinetics, Inc. Announces Clinical And Non-Clinical Data On Ispinesib To Be Presented At The 2005 AACR-NCI-EORTC International Meeting

  11/11/2005

• Cytokinetics, Inc. To Present At The Rodman & Renshaw Techvest 7th Annual Healthcare Conference

  11/1/2005

• Cytokinetics, Inc. Secures $75 Million Committed Equity Financing Facility

  10/31/2005

• Cytokinetics, Inc. Reports Third Quarter 2005 Financial Results

  10/26/2005

• Genentech Lung-Cancer Drug Stirs Excitement On Wall Street

  4/11/2005

• Biotech 2005: New Drugs Hold The Key

  12/29/2004

• Semi-Annual Changes To The NASDAQ Biotechnology Index

  11/15/2004

• Barrier And Cytokinetics Have Strong IPOs

  5/3/2004